Published • loading... • Updated
[Opinion] Jim Cramer Says This Stock Could Rise Like Moderna (MRNA)
Summary by BizToc
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Jim Cramer Says This Stock Could Rise Like Moderna (MRNA)
Mentioning how the FDA advisory panel backed its Galleri multi-cancer early detection test, a caller asked for Jim Cramer's opinion on GRAIL, Inc. (NASDAQ:GRAL) during the lightning round of the September 30 episode of Mad Money. He replied: You know, I've been waiting for that. I've been waiting…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
![[Opinion] EU Faces Economic Reform Deadline Amid Global Competition](/_next/image?url=https%3A%2F%2Fgrnd.b-cdn.net%2Finterests%2F2aefe5c9d007d4c7e8f2e7ac74697cc33782f634.jpg&w=1440&q=75)
